Skip to main content
Caplight Logo









OGI Bio

OGI Bio

Private
EdinburghHealthcare & Life Scienceshttps://ogibiotec.com/

Last Round

VC Round

Jul 22, 2025

Total Funding Raised

$3.02M

Company Overview

OGI Bio is a biotechnology company that develops and provides automated, modular bioreactor systems to streamline and enhance microbial research and culturing processes.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioreactormicrobial culturinglab automationbench-scale bioreactorbiotech equipmentprocess control softwarelaboratory instrumentationfermentation technologybioprocessinglab techautomated labbiotech hardwaresynthetic biology tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OGI Bio Comparables

Compare OGI Bio with similar companies based on industry and business-model similarity.

OGI Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellexus
84%
LAMBDA Laboratory Instruments
81%
Belach Bioteknik AB
78%

OGI Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 22, 2025
SeedJun 4, 2024
SeedMay 30, 2023
SeedApr 29, 2022
Pre SeedMar 1, 2022
Grant
Nov 1, 2020

Key People

Founding team and executive leadership

Alex McVey

Chief Executive Officer, Managing Director, Founder

Founding Team

Elaine Ferguson

CFO

Executive Team

OGI Bio Investors

Notable investors and investment history

OGI Bio investors
InvestorRounds
QUBISSeed
Sapphire Capital PartnersSeed
Apollo Informal InvestmentSeed, VC Round, Pre Seed, Grant
Innovate UKGrant
Old College CapitalSeed
Merleview CapitalSeed, VC Round
The TRICAPITAL SyndicateVC Round, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2025

    Led by Merleview Capital with participation from Apollo Informal Investment.

  • Jun 4, 2024

    $826K round with Apollo Informal Investment and Old College Capital.

OGI Bio Filings

Explore SEC and related filing metadata, where available.

OGI Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OGI Bio's valuation, stock price, and market status.

Is OGI Bio a public or private company?

OGI Bio is a private company.

What is the current stock price of OGI Bio?

OGI Bio is a private company with no public stock price. No recent secondary market data is available.

How much is OGI Bio worth (valuation)?

Valuation information for OGI Bio is not publicly available.

Can I buy OGI Bio stock?

OGI Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OGI Bio's last funding round?

OGI Bio's most recent funding round was Strategic on July 22, 2025.

Who are the main investors in OGI Bio?

Key investors in OGI Bio include Apollo Informal Investment, Merleview Capital.

Will OGI Bio IPO soon?

No public IPO plans have been announced for OGI Bio.

How can I track OGI Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OGI Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdinburgh
Employee Range15
Year Founded2020
Last FundingJul 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?